Tag: Recurrence rate

Explore our medication guides and pharmacology articles within this category.

What is the success rate of mitomycin? A comprehensive guide to outcomes in bladder cancer

Oct 12, 2025 •

4 min read

For non-muscle-invasive bladder cancer (NMIBC), an updated meta-analysis of studies showed a pooled recurrence-free survival (RFS) rate of approximately 67.2% for mitomycin C alone. However, the success rate of mitomycin is highly dependent on multiple factors, including cancer risk, patient profile, and the specific treatment protocol used.